Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy.
Unexplained cardiac hypertrophy, the diagnostic criterion for hypertrophic cardiomyopathy (HCM), occurs in 1 in 500 adults. Insights into the genetic cause and molecular pathophysiology of HCM are reshaping clinical paradigms for diagnosis and treatment of this common myocardial disorder. Human genetic studies have established that dominant mutations in the proteins that make up the contractile apparatus (the sarcomere) cause HCM. With the current availability of clinical gene-based diagnostics, pathogenic mutations in affected patients can be defined, which can suggest a clinical course and allow definitive preclinical identification of family members at risk for HCM. Genetic discoveries have also fostered mechanistic investigations in model organisms that are engineered to carry human HCM mutations. Novel therapeutic targets have emerged from these fundamental studies and are currently under clinical assessment in humans. The combination of contemporary gene-based diagnosis with new strategies to attenuate disease development and progression is changing the natural history of lifelong cardiac symptoms, arrhythmias, and heart failure from HCM.
Wang
Libin
L
Harvard Medical School and Howard Hughes Medical Institute, Boston, Massachusetts, USA.
Seidman
Jonathan G
JG
Seidman
Christine E
CE
D001145:Arrhythmias, Cardiac / Q000209:etiology; D015220:Calcium Channels / Q000378:metabolism; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis* / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy; D005799:Genes, Dominant; D005838:Genotype; D006706:Homeostasis; D006801:Humans; D009154:Mutation
D015220:Calcium Channels
Mayo Clin Proc. 2008 Jun;83(6):630-8
18533079
N Engl J Med. 2008 May 1;358(18):1899-908
18403758
Circ J. 2009 Sep;73(9):1599-605
19590139
J Am Coll Cardiol. 2008 Apr 8;51(14):1369-74
18387438
Nat Clin Pract Cardiovasc Med. 2008 Mar;5(3):158-68
18227814
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2005;:86-91
15818363
Science. 1996 May 3;272(5262):731-4
8614836
J Am Coll Cardiol. 2003 Nov 5;42(9):1687-713
14607462
Br Heart J. 1958 Jan;20(1):1-8
13499764
Lancet. 2004 Jun 5;363(9424):1881-91
15183628
Guys Hosp Rep. 1957;106(4):221-38
13480570
Circulation. 2002 Jun 25;105(25):2992-7
12081993
Am J Physiol Heart Circ Physiol. 2005 Nov;289(5):H2112-9
15994854
N Engl J Med. 2000 Feb 10;342(6):365-73
10666426
J Muscle Res Cell Motil. 2000;21(7):609-20
11227787
N Engl J Med. 2003 Sep 11;349(11):1064-75
12968091
Exp Mol Med. 2004 Jun 30;36(3):193-203
15272230
J Clin Invest. 1994 Jan;93(1):280-5
8282798
Circulation. 2002 Jan 29;105(4):446-51
11815426
N Engl J Med. 2001 Jun 14;344(24):1823-31
11407343
J Clin Invest. 2000 Dec;106(11):1351-9
11104788
J Clin Invest. 1998 Oct 1;102(7):1292-300
9769321
J Med Genet. 2005 Oct;42(10):e59
16199542
Circulation. 2005 Nov 1;112(18):2805-11
16267253
JAMA. 2009 Mar 25;301(12):1253-9
19318653
Circulation. 2006 Jul 18;114(3):216-25
16831987
Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H284-91
17351073
J Clin Invest. 2005 Mar;115(3):556-64
15765137
Heart. 2008 Oct;94(10):1269-75
18653582
N Engl J Med. 2005 Jan 27;352(4):362-72
15673802
JACC Cardiovasc Interv. 2008 Oct;1(5):561-70
19463359
N Engl J Med. 1992 Apr 23;326(17):1108-14
1552912
J Cardiol. 2008 Oct;52(2):146-53
18922389
J Clin Invest. 1999 Dec;104(12):1683-92
10606622
FASEB J. 2007 Dec;21(14):3974-85
17606808
N Engl J Med. 2007 Feb 22;356(8):830-40
17314342
Cell. 2001 Feb 23;104(4):557-67
11239412
J Cardiovasc Electrophysiol. 2008 Jan;19(1):104-10
17916152
Circ Heart Fail. 2009 May;2(3):253-61
19808347
Circulation. 2009 Mar 17;119(10):1398-407
19255346
Curr Opin Cardiol. 2008 May;23(3):199-205
18382207
N Engl J Med. 1995 Apr 20;332(16):1058-64
7898523
Heart. 2008 Oct;94(10):1264-8
18653576
Circulation. 1998 Dec 1;98(22):2415-21
9832486
J Mol Cell Cardiol. 2007 Jun;42(6):1098-110
17490679
J Clin Invest. 1999 Aug;104(4):469-81
10449439
J Clin Invest. 2002 Feb;109(3):357-62
11827995
JAMA. 2002 Mar 13;287(10):1308-20
11886323
Circulation. 2001 Sep 18;104(12):1380-4
11560853
BMJ. 2006 May 27;332(7552):1251-5
16735335
Int Heart J. 2007 Nov;48(6):715-24
18160763
J Biol Chem. 2001 Feb 9;276(6):3743-55
11060294
J Clin Invest. 2008 Dec;118(12):3893-903
19033660
J Mol Diagn. 2009 Jan;11(1):35-41
19074594
JACC Cardiovasc Interv. 2008 Aug;1(4):432-8
19463341
Am J Cardiol. 2001 Aug 1;88(3):275-9
11472707
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18123-8
16332958
Nat Med. 1999 Mar;5(3):327-30
10086390
Hum Mol Genet. 2001 May 15;10(11):1215-20
11371514
Clin Cardiol. 2008 Mar;31(3):114-8
18383048
J Clin Invest. 2002 Apr;109(8):1013-20
11956238
Nat Genet. 2009 Feb;41(2):187-91
19151713
N Engl J Med. 2004 Mar 25;350(13):1320-7
15044643
Annu Rev Genomics Hum Genet. 2005;6:185-216
16124859
N Engl J Med. 1997 Mar 13;336(11):775-85
9052657
Heart. 2008 Oct;94(10):1276-81
18653577
N Engl J Med. 1998 Apr 30;338(18):1248-57
9562578
Heart. 2003 Oct;89(10):1179-85
12975413
Circ Res. 2001 Mar 2;88(4):383-9
11230104
Circulation. 2001 Feb 13;103(6):789-91
11171784